Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based studyKuniko Sunami, Takashi Kohno, Mayuko Kitami et al.|Cancer Science|2019Cited by 375
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cellsHirokazu Taniguchi, Seiji Yano|Nature Communications|2019Cited by 360
Targeted Therapies and Biomarkers in Small Cell Lung CancerHirokazu Taniguchi, Charles M. Rudin|Frontiers in Oncology|2020Cited by 112
Amphiregulin triggered epidermal growth factor receptor activation confers <i>in vivo</i> crizotinib‐resistance of <scp>EML</scp>4‐<scp>ALK</scp> lung cancer and circumvention by epidermal growth factor receptor inhibitorsHirokazu Taniguchi, Seiji Yano|Cancer Science|2016Cited by 33